Andria Moran, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Rosewood Village Dr, Swansea, IL 62226 Phone: 618-236-1391 |
Morgan Muehler Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1 Bronze Pointe Blvd Ste 2a, Swansea, IL 62226 Phone: 833-587-1784 |
Anna Winkeler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4275 Biverton Dr, Swansea, IL 62226 Phone: 402-671-3096 |
Elizabeth Angela Haldeman, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4941 Benchmark Centre Dr, Swansea, IL 62226 Phone: 763-313-4343 |
Bethany Lynn Kipping Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 Castellano Dr, Swansea, IL 62226 Phone: 618-416-6161 Fax: 618-416-6181 |
Elizabeth Mary Kuerz, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Swansea Rehab And Health, 1405 North Second Street, Swansea, IL 62226 Phone: 618-233-6625 |
Lindsey Neyland, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1405 N 2nd St, Swansea, IL 62226 Phone: 618-233-6625 |
Mrs. Janine Gullick Bridenbaugh, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 Huntwood Rd, Swansea, IL 62226 Phone: 618-277-2100 |
Bonnie Jo Leveling, MA CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 87 Grimmig Rd, Swansea, IL 62226 Phone: 618-257-9201 |
Mrs. Hannah Joy Werner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4381 Shelfield Ct, Swansea, IL 62226 Phone: 618-210-9113 |
News Archive
In obesity, the body's immune system can treat tissues as if they are suffering from a low-grade chronic infection. This obesity-induced inflammation is an important contributor to insulin resistance, a condition that can progress into type 2 diabetes.
A research team led by Robert Gerszten, MD, Chief of Cardiovascular Medicine at Beth Israel Deaconess Medical Center and a Senior Associate Member of the Broad Institute, has received an award of more than $11 million as part of the Molecular Transducers of Physical Activity in Humans consortium, a large-scale initiative of the National Institutes of Health to investigate and map the molecular changes that occur in our bodies during and after exercise.
Catalyst Pharmaceutical Partners, Inc. today announced positive results from a series of CPP-115 preclinical safety and efficacy evaluations. CPP-115 was found to have a significantly improved retinal safety profile compared to vigabatrin.
Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren't always practical because must be implanted surgically.
› Verified 9 days ago